Cited by 361Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid Surgery

Efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of mainland China.

Li, Yongze, Teng, Di, Ba, Jianming, Chen, Bing, Du, Jianling, He, Lanjie, Lai, Xiaoyang, Teng, Xiaochun +31 more·2020·Thyroid

Abstract

Background: Mandatory universal salt iodization (USI) has been implemented in China for 20 years. Although iodine deficiency disorders are effectively controlled, the risk of excess iodine have been debated. Methods: A nationally representative cross-sectional study with 78,470 enrolled participants, aged 18 years or older, from all 31 provincial regions of mainland China was performed. The participants were given a questionnaire and underwent B-mode ultrasonography of the thyroid. Serum concentrations of thyroid hormones, thyroid antibodies, and urine iodine concentration (UIC) were measured. Results: The median UIC of the adult population was 177.89 μg/L. The weighted prevalence of thyroid disorders in adults were as follows: 0.78% of overt hyperthyroidism, 0.44% of subclinical hyperthyroidism, 0.53% of Graves' disease, 1.02% of overt hypothyroidism, 12.93% of subclinical hypothyroidism, 14.19% of positive thyroid antibodies, 10.19% of positive thyroid peroxidase antibodies, 9.70% of positive thyroglobulin antibodies, 1.17% of goiter, and 20.43% of thyroid nodules. Iodine excess was only associated with higher odds of overt hyperthyroidism and subclinical hypothyroidism, while iodine deficiency was significantly associated with higher odds of most thyroid disorders. In addition, increased iodine intake was significantly associated with elevated serum thyrotropin levels but was inversely associated with thyroid antibodies and thyroid nodules. Conclusions: The long-term mandatory USI program with timely adjustments is successful in preventing iodine deficiency disorders, and it appears to be safe. The benefits outweigh the risks in a population with a stable median iodine intake level of up to 300 μg/L.

Integrity signals

Registry

Crossref · 10.1089/thy.2019.0067

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Following iodine prophylaxis in China, the incidence of thyroid autoantibodies decreased to similar levels as before iodine prophylaxis was implemented, indicating that the effect of early iodine-induced thyroid autoimmunity was transient.

    “The results showed that following iodine prophylaxis, the incidence of thyroid autoantibodies decreased to similar levels as before iodine prophylaxis was implemented, indicating that the effect of early iodineinduced thyroid autoimmunity was transient.67”

    From Hypothyroidism (2024) · cites this paper as [67]

  • Hypothyroidism may affect up to 12% of the population, primarily as subclinical hypothyroidism, with higher prevalence in areas with inadequate nutritional iodine levels.

    “The prevalence in North America and Europe ranges from 0.3%to2%, 3-5 but may affect up to 12% of the population, primarily as subclinical hypothyroidism,withhigherprevalenceinareaswith inadequate nutritional iodine levels. 2,6”

    From Hypothyroidism: A Review (2025) · cites this paper as [6]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Li, Y., Teng, D., Ba, J., Chen, B., Du, J., He, L., Lai, X., Teng, X., Shi, X., Li, Y., Chi, H., Liao, E., Liu, C., Liu, L., Qin, G., Qin, Y., Quan, H., Shi, B., Sun, H., Tang, X., Tong, N., Wang, G., Zhang, J.-A., Wang, Y., Xue, Y., Yan, L., Yang, J., Yang, L., Yao, Y., Ye, Z., Zhang, Q., Zhang, L., Zhu, J., Zhu, M., Ning, G., Mu, Y., Zhao, J., Shan, Z., & Teng, W.
Affiliations
  • Harbin Medical University (CN)
  • First Hospital of China Medical University (CN)
  • Chinese PLA General Hospital (CN)
  • Army Medical University (CN)
  • First Affiliated Hospital of Dalian Medical University (CN)
  • Ningxia Medical University (CN)
  • Second Affiliated Hospital of Nanchang University (CN)
  • Hohhot First Hospital (CN)
  • Central South University (CN)
  • Nanjing University of Chinese Medicine (CN)
  • Fujian Medical University (CN)
  • Zhengzhou University (CN)
  • First Affiliated Hospital of GuangXi Medical University (CN)
  • Hainan General Hospital (CN)
  • First Affiliated Hospital of Xi'an Jiaotong University (CN)
  • Wuhan Union Hospital (CN)
  • First Hospital of Lanzhou University (CN)
  • Sichuan University (CN)
  • First Hospital of Jilin University (CN)
  • Shanghai University of Medicine and Health Sciences (CN)
  • Anhui Medical University (CN)
  • First People's Hospital of Yunnan Province (CN)
  • Sun Yat-sen University (CN)
  • Shanxi Medical University (CN)
  • Tibet Autonomous Region People's Hospital (CN)
  • Qinghai Provincial Peoples Hospital (CN)
  • Zhejiang Center for Disease Control and Prevention (CN)
  • Guiyang Medical University (CN)
  • Second Hospital of Hebei Medical University (CN)
  • First Affiliated Hospital of Xinjiang Medical University (CN)
  • Tianjin Medical University General Hospital (CN)
  • Shanghai Jiao Tong University (CN)
  • Shandong University (CN)
Corresponding author
  • Shan, Zhongyan
  • Teng, Weiping
Venue
Thyroid
Published
2020-04-01
Volume
30
Issue
4
Pages
568-579
ISSN
  • 1050-7256 (ISSN-L)
  • 1557-9077
OpenAlex
W3007310873
Cited by
359
References
25
Citations by year
2026: 40 · 2025: 60 · 2024: 80 · 2023: 59 · 2022: 57 · 2021: 50 · 2020: 12 · 2013: 1
FWCI
33.94
Type
journal article
Language
en
Open access
closed
Locations
  • Thyroid (publishedVersion)
  • PubMed (publishedVersion)
  • Lanzhou University Institutional Repository (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
Keywords
universal salt iodization, iodine excess, iodine deficiency disorders, thyroid dysfunction, urinary iodine, overt hyperthyroidism, subclinical hypothyroidism, Graves' disease, thyroid autoantibodies, thyroid peroxidase antibodies, thyroglobulin antibodies, thyroid nodules, goiter, thyroid-stimulating hormone, iodine intake, China
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, China, Cross-Sectional Studies, Female, Humans, Hyperthyroidism, Hypothyroidism, Iodine, Male, Middle Aged, Thyroid Gland, Ultrasonography, Prevalence, Sodium Chloride, Dietary, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review